Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.
about
Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patientsOverview and recent advances in the treatment of neuroblastoma.Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.Neuroblastoma: molecular pathogenesis and therapy.Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter studyAdvances in Risk Classification and Treatment Strategies for Neuroblastoma.Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastomaAdvances in paediatric cancer treatmentSIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsIs complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?Ten challenges in the management of neuroblastoma.Children's Oncology Group's 2013 blueprint for research: neuroblastoma.Emerging drugs for neuroblastoma.Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015.Genetic discoveries and treatment advances in neuroblastoma.Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.Advances in emerging drugs for the treatment of neuroblastoma.Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.Invariant natural killer T infiltration in neuroblastoma with favorable outcome.A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies.Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donorsMinimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth
P2860
Q28304289-E28C99B4-2433-460C-A3F7-B5C6545BEA6EQ30238693-4B021A10-47CF-4DD9-9183-D96E39568A2CQ34606771-1734016E-438F-40E7-B3CF-4111B4DABEA1Q35564199-3BED695B-B99F-4CDF-9E19-39EBDD1B15CAQ35870376-DAD4A77F-BC70-415F-A9D2-4ABF386380C0Q36053801-D86F164D-0F0E-4BFD-8098-F270F44B223EQ36058508-2F76760F-1D07-4D43-A084-59A584435A09Q36446812-24EF5A3E-488E-4D42-B267-E9B512E3B241Q36508630-82830026-5F38-488F-A901-063E4A70B0E7Q37461968-491075F7-F6D1-4261-895D-C950D63974D4Q38020759-BC5A8084-8EDB-4056-90FD-BE57584E22D0Q38029366-20CC54D2-511B-4EDB-A671-DADD98443744Q38068818-45571BB3-8674-4F52-B46D-206AD4630873Q38108399-4FFD8572-2877-4F96-8DB1-22BABE390D44Q38635452-20825697-630B-4A1A-9DE0-42CB3E918CF3Q38635551-37CB3932-31BF-45D7-A809-B61F91CC085EQ38804821-80ED403B-6CB2-4811-B749-9EDE784949B7Q39158415-50BF97FC-46DC-4B94-940E-C50DA110DE42Q39866458-C6D20869-2D2D-47D0-B9DC-9C9106089D7DQ40229142-A738A9C0-7B46-40F9-9D7F-B8E9F26119F7Q41250708-34D7CC4E-2847-4269-B3A9-78849A1692DBQ41462612-9CAF5C91-937F-4559-8F6A-5C6128701A58Q50091814-CA962677-0123-413E-97E6-DC9544E3BE34Q50329262-D4782114-43EC-41F4-8D37-9A8EA1174B1CQ53075722-15516813-5435-4048-95A0-DB2C63255248Q54265705-1A4DCEBF-FA2D-46BB-A328-D6880A43CADCQ54362742-B6D0677C-E5E8-4CFC-83D6-AE504896A924Q57214141-BD817DDC-60B0-46EE-A235-98FF04FB8EA4
P2860
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Treatment of localised resecta ...... OP Europe Neuroblastoma Group.
@en
type
label
Treatment of localised resecta ...... OP Europe Neuroblastoma Group.
@en
prefLabel
Treatment of localised resecta ...... OP Europe Neuroblastoma Group.
@en
P2093
P2860
P50
P356
P1476
Treatment of localised resecta ...... IOP Europe Neuroblastoma Group
@en
P2093
A D J Pearson
A F de Lacerda
B De Bernardi
J De Kraker
M Beck-Popovic
R Ladenstein
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604640
P407
P577
2008-09-02T00:00:00Z